ISLET-CELL FUNCTION IN TYPE-1 AND TYPE-2 DIABETES

Authors
Citation
W. Hao et Jp. Palmer, ISLET-CELL FUNCTION IN TYPE-1 AND TYPE-2 DIABETES, Journal of clinical ligand assay, 21(3), 1998, pp. 309-317
Citations number
80
Categorie Soggetti
Biochemical Research Methods","Medical Laboratory Technology",Immunology
ISSN journal
10811672
Volume
21
Issue
3
Year of publication
1998
Pages
309 - 317
Database
ISI
SICI code
1081-1672(1998)21:3<309:IFITAT>2.0.ZU;2-6
Abstract
The primary hormone controlling glucose metabolism is insulin. A defic iency in insulin secretion is a central defect in the pathophysiology of both type 1 and type 2 diabetes. In this review we discuss the abno rmalities of insulin secretion characteristic of both forms of diabete s. We describe most of the commonly employed tests of beta cell functi on and explore their relative advantages and disadvantages. Usually, t here is a trade-off between the complexity of the test and the amount of information obtained. For example, measuring insulin or C-peptide d uring the fasting state provides far less information on total beta ce ll functional capacity than does dynamic beta cell testing at differen t glucose levels using several intravenous beta cell secretagogues. Si nce insulin and C-peptide are the primary measurements used during bet a cell testing, a few caveats are provided regarding both of these ass ays and the interpretation of results.